Journal of Veterinary Clinics (한국임상수의학회지)

The Korean Society of Veterinary Clinics (한국임상수의학회)
권호 표지

Killing Rate Curve and Antivacterial Activity against Various Pathogenic Bacteria in the Presence of Enrofloxacin and Colistin

병원성미생물에 대한 Enrofloxacin과 Colistin의 배합비육에 따른 항균작용과 균의 사멸속도

  • Published : 1997.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Enrofloxacin-colistin combination, widely used in Gram negative infections in veterinary sector, was investigated in terms of MIC and initial killing rate using E coli k 88ab, Salmonella typhimurium, Pasteurella multocida type A, Bordetella bronchiseptica and Staphylococcus aureus as test organisms. On the basis of MICs of enrofloxacin-colistin combination against the above bacteria, killing rates of the combination of enrofloxacin and colistin at the ratio of 5:0, 4:1, 3:2, 1:1, 2:3, 1:4 and 0:5, indicated high and rapid antibacterial acitivities against all but Staphylococcus aureus R-209, with the number of bacteria reducing to less than one percent within two hours. At the MIC of enrofloxacin or colistin, both antibacterials showed the highest killing rates during 2-4 hours against Gram negatives such as E coli K88ab,Pasteurella multocida type A and Bodetella bronchiseptica but allowed the regrowth of the same pathogens thereafter. On the while, the combination of two antibacterials at a fourth MIC resulted in high killing rate without bacterial regrowth during 24 hours, suggesting the synergistic antivacterial effects. The combination, however, did not show favourable activity against Gram negatime S typhimurium and Gram positive S aureus ergistic antibacterial activity against Gram negatime pathogens but also colistin showed LPS-neutraization, we could suggest the combination should provide clinically positive therapeutic armarium in Gram negative infections.

Keywords

References

  1. Am J Vet Res v.56 Pharmacokinetics and residues of enrofloxacin in chickens Anadon A;Martinez-Larranaga MR;Diaz MJ
  2. Scand J Infect Dis v.23 Effect of different type and combinations of antimcirobial agent on endotoxin release from gram-negative bacteria: An in-vitro and in-vivo study Anthonius MD;Nijland GV;Hilly OM;Paula JW
  3. J Vet Pharma Therap v.13 The comparative of a new quinolone, enrofloxacin in dogs, horses, calves, chickens, and turkeys Babish JW;Davidson J
  4. Principles of Drug Disposition in Domestic Animals(2nd ed) General principles governing translocation of drugs Baggot JD
  5. Am J Vet Res v.52 Pharmacokinetic properties of enrofloxacin in rabbits Broome RL;Brooks DL;Babish JG
  6. Eur J Microbiol Infect Dis v.13 Differential antibioric-induced release of endotoxin from gram-negative bactera Bucklin SE;Fujihara MC Leeson DC
  7. Antimicrob Agent Chemothera v.13 Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B David CM;Diane MJ
  8. J. Bacteriol v.92 Neutralization of endotoxin toxicity in chick embryo by antibiotics David R;John DP
  9. Antimicrob Agent Chemothera v.40 Comparison of methodologes for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa Diane MC;Michael JR
  10. J. Bacteriol v.168 Control of lipopolysaccharide biosynthesis and release by Escherichia coli and Salmonella typhimutium Edward EI;Desiree V;Kusser W
  11. J Med Microbiol v.40 Antibiotic-induced release of endotoxin from bacteria in vitro Heather AC;Bion JF;Penn CW;Elliott TSJ
  12. Am J surgery v.167 Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber Hirohiko AK;Masashi T;Tohru HK
  13. Quinolone Atimicrobial Agents(2nd ed) v.3 Mechanism of quinolone action and bacterial killing Hooper DC(ed.);Wolfson JS
  14. Antimicrob Agent Chemothera v.35 Antibiotic-induced release of endotoxin in chronically bacteriuric patients Hurley JC;Louis WJ;Tosolini FA;Carlin JB
  15. Antimicrob Agent Chemothera v.38 Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice Itzhak OC;Sopfie R;Rita K;Kisra T;Dove H;Yaacov RE
  16. J Vet Parmacol Therap v.17 Kinetics of endotoxin, complement and platelet-activating factor(PAF) induced vascular permeability in greyhaunds Milis PC;Sawright AA;Auer DE
  17. Antimicrob Agent Chemothera v.39 Prevention of experimental endotoxin shock by a monocyte activator Passlick B;Labeta MO;Izbicki JR;Ostertag P;Loffler T;Siebeck M
  18. Antimicrob Agent Chemothera v.33 Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide Robert LD;Keith AJ;Marc R;William HP;Nelson J;Kenneth MA;Joseph EP
  19. J Vet Parmacol Therap v.16 Effect of endotoxin on tirilazad mesylate (U74006F) pharmacokinetic parameters in neonatal calves Rose ML;Semard SD;Putnam SL;Brown SA
  20. J Surgical Reaserch v.59 Pharmacokinetics of endotoxin in a rhuseus macaque septic shock model Shyamal P;Michael LM;Cass KN;Mcnamara JJ
  21. Cornell Vet v.80 The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity Vancutsem PM;Babish jG;Schwark WS
  22. Antimicrob Agent Chemotherapy v.35 Endotoxin-to-bramycin additive toxicity on renal proximal tubular cells in culture Veronique JB;Yves GB;Michel CC
  23. Antimicrob Agent Chemothera v.38 Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide Warren HS;Sthephen AK;George RS